IN8BIO, INC. — Director's Dealing 2024

Oct 8, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2024-10-04

Reporting Person: Roemer Alan S. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-10-04	Common Stock	A	126582	—	Acquired	285030	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-10-04	Series A Warrants (right to buy)	$1.25	D	102459	Disposed	2025-06-13	Common Stock (102459)	Direct
2024-10-04	Series A Warrants (right to buy)	$0.45	A	102459	Acquired	2025-10-04	Common Stock (102459)	Direct
2024-10-04	Series C Warrants (right to buy)	$0.27	A	126582	Acquired	2027-10-04	Common Stock (126582)	Direct

Footnotes

F1: The reported securities are included within 126,582 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 126,582 shares of common stock.

F2: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F3: Fully vested and exercisable.

F4: The reported securities are included within 102,459 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 102,459 shares of common stock.